Erlotinib, erlotinib-sulindac versus placebo: A randomized, double-blind, placebo-controlled window trial in operable head and neck cancer
- Neil D. Gross
- , Julie E. Bauman
- , William E. Gooding
- , William Denq
- , Sufi M. Thomas
- , Lin Wang
- , Simion Chiosea
- , Brian L. Hood
- , Melanie S. Flint
- , Mai Sun
- , Thomas P. Conrads
- , Robert L. Ferris
- , Jonas T. Johnson
- , Seungwon Kim
- , Athanassios Argiris
- , Lori Wirth
- , Marina N. Nikiforova
- , Jill M. Siegfried
- , Jennifer R. Grandis
Research output: Contribution to journal › Article › peer-review
52
Link opens in a new tab
Scopus
citations